Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Buying opportunity - Market maker out of business -- Ignore unavailable to you. Want to Upgrade?

To: Mike J who wrote (320)	2/24/1998 11:55:00 AM
From: Master (Hijacked)	Read Replies (1) \| Respond to of 472

On FLEM, I don't know if they'll answer, but ask what are the "two development agreements with major pharmaceutical companies" they have right now and are they for HIGH VOLUME OTC drugs and is the development FUNDED by the pharmaceutical companies or FLEM? Because the way they're going, with going through FDA trials and little or no funding help, FLEM will need significant financing and share dilution over the next few years to see their first dime in revenue. Thats not too bad if you're the CEO and are getting paid $200K/year, but the shareholders will definitely suffer if they pursue this costly and risky business plan.